These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 11372673)

  • 1. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms.
    Joop K; Berckmans RJ; Nieuwland R; Berkhout J; Romijn FP; Hack CE; Sturk A
    Thromb Haemost; 2001 May; 85(5):810-20. PubMed ID: 11372673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation.
    Berckmans RJ; Nieuwland R; Böing AN; Romijn FP; Hack CE; Sturk A
    Thromb Haemost; 2001 Apr; 85(4):639-46. PubMed ID: 11341498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-specific and menstrual cycle dependent differences in circulating microparticles.
    Toth B; Nikolajek K; Rank A; Nieuwland R; Lohse P; Pihusch V; Friese K; Thaler CJ
    Platelets; 2007 Nov; 18(7):515-21. PubMed ID: 17957567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic changes in haemostatic balance are not associated with increased levels of circulating microparticles in women with recurrent spontaneous abortion.
    Toth B; Nieuwland R; Kern M; Rogenhofer N; Berkmans R; Rank A; Lohse P; Friese K; Thaler CJ
    Am J Reprod Immunol; 2008 Feb; 59(2):159-66. PubMed ID: 18211541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived microparticles and coagulation activation in breast cancer patients.
    Toth B; Liebhardt S; Steinig K; Ditsch N; Rank A; Bauerfeind I; Spannagl M; Friese K; Reininger AJ
    Thromb Haemost; 2008 Oct; 100(4):663-9. PubMed ID: 18841290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism.
    Berckmans RJ; Nieuwland R; Tak PP; Böing AN; Romijn FP; Kraan MC; Breedveld FC; Hack CE; Sturk A
    Arthritis Rheum; 2002 Nov; 46(11):2857-66. PubMed ID: 12428225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticle-associated P-selectin reflects platelet activation in preeclampsia.
    Lok CA; Nieuwland R; Sturk A; Hau CM; Boer K; Vanbavel E; Vanderpost JA
    Platelets; 2007 Feb; 18(1):68-72. PubMed ID: 17365856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of circulating endothelial and platelet microparticles in men with ankylosing spondylitis.
    Sari I; Bozkaya G; Kirbiyik H; Alacacioglu A; Ates H; Sop G; Can G; Taylan A; Piskin O; Yildiz Y; Akkoc N
    J Rheumatol; 2012 Mar; 39(3):594-9. PubMed ID: 22247348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation.
    van der Zee PM; Biró E; Trouw LA; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
    Clin Immunol; 2010 Jun; 135(3):490-5. PubMed ID: 20138585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress.
    Helal O; Defoort C; Robert S; Marin C; Lesavre N; Lopez-Miranda J; Risérus U; Basu S; Lovegrove J; McMonagle J; Roche HM; Dignat-George F; Lairon D
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):665-71. PubMed ID: 20399083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties.
    Abid Hussein MN; Böing AN; Biró E; Hoek FJ; Vogel GM; Meuleman DG; Sturk A; Nieuwland R
    Thromb Res; 2008; 121(6):865-71. PubMed ID: 17889282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombogenesis in sickle cell disease.
    Tomer A; Harker LA; Kasey S; Eckman JR
    J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
    Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.
    Amabile N; Guérin AP; Leroyer A; Mallat Z; Nguyen C; Boddaert J; London GM; Tedgui A; Boulanger CM
    J Am Soc Nephrol; 2005 Nov; 16(11):3381-8. PubMed ID: 16192427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head.
    Kang P; Shen B; Yang J; Pei F
    Thromb Res; 2008; 123(2):367-73. PubMed ID: 18495220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls.
    Collins PW; Macchiavello LI; Lewis SJ; Macartney NJ; Saayman AG; Luddington R; Baglin T; Findlay GP
    Br J Haematol; 2006 Oct; 135(2):220-7. PubMed ID: 17010048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
    Tomer A; Kasey S; Connor WE; Clark S; Harker LA; Eckman JR
    Thromb Haemost; 2001 Jun; 85(6):966-74. PubMed ID: 11434703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.